- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report focuses on the Antifungal Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Antifungal Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Novartis
Pfizer
Sanofi
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GlaxoSmithKline
Abbott
J & J
Teva
Mylan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Azoles
Echinocandins
Polyenes
Allylamines
Others
Market Segment by Applications, can be divided into
Dermatophytosis
Aspergillosis
Candidiasis
Others
There are 15 Chapters to deeply display the global Antifungal Drugs market.
Chapter 1, to describe Antifungal Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antifungal Drugs, with sales, revenue, and price of Antifungal Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antifungal Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antifungal Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antifungal Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antifungal Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Azoles
1.2.2 Echinocandins
1.2.3 Polyenes
1.2.4 Allylamines
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Dermatophytosis
1.3.2 Aspergillosis
1.3.3 Candidiasis
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Antifungal Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Antifungal Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Antifungal Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Antifungal Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Enzon Pharmaceuticals
2.5.1 Business Overview
2.5.2 Antifungal Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Enzon Pharmaceuticals Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Antifungal Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Astellas Pharma
2.7.1 Business Overview
2.7.2 Antifungal Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Astellas Pharma Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GlaxoSmithKline
2.8.1 Business Overview
2.8.2 Antifungal Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Abbott
2.9.1 Business Overview
2.9.2 Antifungal Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Abbott Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 J & J
2.10.1 Business Overview
2.10.2 Antifungal Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 J & J Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Teva
2.11.1 Business Overview
2.11.2 Antifungal Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Teva Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Mylan
2.12.1 Business Overview
2.12.2 Antifungal Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Mylan Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antifungal Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antifungal Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antifungal Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antifungal Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Antifungal Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antifungal Drugs Market Analysis by Regions
4.1 Global Antifungal Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antifungal Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antifungal Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Antifungal Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Antifungal Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antifungal Drugs Sales and Growth Rate (2013-2018)
4.5 South America Antifungal Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antifungal Drugs Sales and Growth Rate (2013-2018)
5 North America Antifungal Drugs by Countries
5.1 North America Antifungal Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Antifungal Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antifungal Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Antifungal Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Antifungal Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Antifungal Drugs Sales and Growth Rate (2013-2018)
6 Europe Antifungal Drugs by Countries
6.1 Europe Antifungal Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Antifungal Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antifungal Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antifungal Drugs Sales and Growth Rate (2013-2018)
6.3 UK Antifungal Drugs Sales and Growth Rate (2013-2018)
6.4 France Antifungal Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Antifungal Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Antifungal Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antifungal Drugs by Countries
7.1 Asia-Pacific Antifungal Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antifungal Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antifungal Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Antifungal Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Antifungal Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Antifungal Drugs Sales and Growth Rate (2013-2018)
7.5 India Antifungal Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antifungal Drugs Sales and Growth Rate (2013-2018)
8 South America Antifungal Drugs by Countries
8.1 South America Antifungal Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Antifungal Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antifungal Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antifungal Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Antifungal Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Antifungal Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antifungal Drugs by Countries
9.1 Middle East and Africa Antifungal Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antifungal Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antifungal Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antifungal Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Antifungal Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Antifungal Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Antifungal Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Antifungal Drugs Sales and Growth Rate (2013-2018)
10 Global Antifungal Drugs Market Segment by Type
10.1 Global Antifungal Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antifungal Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Antifungal Drugs Revenue and Market Share by Type (2013-2018)
10.2 Azoles Sales Growth and Price
10.2.1 Global Azoles Sales Growth (2013-2018)
10.2.2 Global Azoles Price (2013-2018)
10.3 Echinocandins Sales Growth and Price
10.3.1 Global Echinocandins Sales Growth (2013-2018)
10.3.2 Global Echinocandins Price (2013-2018)
10.4 Polyenes Sales Growth and Price
10.4.1 Global Polyenes Sales Growth (2013-2018)
10.4.2 Global Polyenes Price (2013-2018)
10.5 Allylamines Sales Growth and Price
10.5.1 Global Allylamines Sales Growth (2013-2018)
10.5.2 Global Allylamines Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Antifungal Drugs Market Segment by Application
11.1 Global Antifungal Drugs Sales Market Share by Application (2013-2018)
11.2 Dermatophytosis Sales Growth (2013-2018)
11.3 Aspergillosis Sales Growth (2013-2018)
11.4 Candidiasis Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Antifungal Drugs Market Forecast (2018-2023)
12.1 Global Antifungal Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Antifungal Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Antifungal Drugs Market Forecast (2018-2023)
12.2.2 Europe Antifungal Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antifungal Drugs Market Forecast (2018-2023)
12.2.4 South America Antifungal Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antifungal Drugs Market Forecast (2018-2023)
12.3 Antifungal Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Antifungal Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Antifungal Drugs Market Share Forecast by Type (2018-2023)
12.4 Antifungal Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Antifungal Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Antifungal Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antifungal Drugs Picture
Table Product Specifications of Antifungal Drugs
Figure Global Sales Market Share of Antifungal Drugs by Types in 2017
Table An
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
